Institute of Molecular Cell Biology
Dr. Wee-Wei Tee did his Ph.D. with Prof Azim Surani at the University of Cambridge, UK, under a Wellcome Trust Ph.D. scholarship. During his Ph.D, Wee-Wei developed a keen interest in understanding the epigenetic control of cell fate plasticity. Thereafter, he joined the laboratory of Prof. Danny Reinberg, a renowned chromatin biochemist and Howard Hughes Investigator at New York University School of Medicine, for his postdoctoral training. He focused his studies on deciphering the mechanistic principles of epigenetic gene silencing, particularly over genes regulated by the Polycomb Repressive Complex 2. Wee-Wei completed his postdoctoral training in September 2015. He has won several fellowships and awards, including the New York Stem Cell Foundation Druckenmiller postdoctoral fellowship and the highly competitive NIH Pathway to Independence (K99/R00) Award. In 2016, Wee-Wei was awarded the Singapore National Research Foundation (NRF) Fellowship (Class of 2016). He is currently a Principal Investigator at A*STAR-IMCB, and also an Assistant Professor at the Department of Physiology, NUS Medicine. His laboratory is interested to study how transcriptional and chromatin aberrancies promote tumorigenesis that will guide the development of new epigenetic-based therapies in cancer.